Find uplifting stories about heroes, innovations, and solutions
9 results for "rheumatoid arthritis"
Scientists at Monash University discovered a tick protein that blocks immune signals linked to multiple sclerosis, rheumatoid arthritis, and cancer. This natural protein could lead to more effective treatments for diseases that currently have limited options.
Researchers at New York's Feinstein Institutes transformed a dangerous immune trigger into a breakthrough therapy that could save lives from sepsis and rheumatoid arthritis. The treatment activates only where disease strikes, sparing healthy immune function.
Scientists at Washington State University discovered why common arthritis drugs fail for 40% of patients and found a promising path to better treatments. The breakthrough reveals a "backdoor" inflammation pathway that could transform care for millions worldwide.
Researchers can now predict rheumatoid arthritis up to five years before symptoms appear, opening the door to preventing the painful disease entirely. Clinical trials are testing whether short treatments could stop the condition before it starts.
Researchers can now detect rheumatoid arthritis up to five years before symptoms appear, opening the door to prevent the disease before it causes joint damage. Clinical trials are already testing treatments that could stop this painful condition in its tracks.
A major new study shows eating Mediterranean and anti-inflammatory diets could slash your risk of developing rheumatoid arthritis by nearly half. For the 1.5 million Americans living with this painful autoimmune disease, the research offers hope that simple food choices might prevent others from developing it.
A single year of treatment can delay rheumatoid arthritis for up to four years in high-risk patients, offering hope to half a million people in the UK living with this painful condition. The benefits lasted long after treatment stopped.
Scientists discovered that a one-year treatment can postpone the painful joint condition rheumatoid arthritis for up to four years, even after stopping the medication. The breakthrough offers hope to 400,000 people in the UK living with or at risk of developing this life-altering autoimmune disease.
Scientists discovered that a single year of treatment with abatacept can delay rheumatoid arthritis development by up to four years, even after stopping the medication. The breakthrough offers hope to 400,000 UK patients living with the painful autoimmune condition.